MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment
Chunyan Gu(Nanjing University of Chinese Medicine), Ye Yang(Yangtze University)
Cited by 14
Related Papers
Alternative splicing and cancer: a systematic review
|Signal Transduction and Targeted Therapy|2021|489
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
|Oncotarget|2014|72
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
|Molecular Cancer|2021|72
BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability
|Signal Transduction and Targeted Therapy|2021|68
A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing
|Journal of Experimental & Clinical Cancer Research|2022|53